| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9745 |
| Human Intestinal Absorption | HIA+ | 0.9165 |
| Caco-2 Permeability | Caco2+ | 0.6320 |
| P-glycoprotein Substrate | Non-substrate | 0.9046 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9917 |
| Non-inhibitor | 0.9929 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9439 |
| Distribution |
| Subcellular localization | Mitochondria | 0.6560 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8434 |
| CYP450 2D6 Substrate | Non-substrate | 0.9406 |
| CYP450 3A4 Substrate | Non-substrate | 0.8176 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.8636 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9468 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9599 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9709 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9870 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9793 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9709 |
| Non-inhibitor | 0.9897 |
| AMES Toxicity | Non AMES toxic | 0.9393 |
| Carcinogens | Carcinogens | 0.5954 |
| Fish Toxicity | Low FHMT | 0.5280 |
| Tetrahymena Pyriformis Toxicity | Low TPT | 0.9671 |
| Honey Bee Toxicity | High HBT | 0.8053 |
| Biodegradation | Ready biodegradable | 0.9840 |
| Acute Oral Toxicity | III | 0.7123 |
| Carcinogenicity (Three-class) | Non-required | 0.6667 |